Evidence map›Paper›PMID 40198614›Full record

ArticlePLOS global public health2025

Enhancing capacities in genomic surveillance capabilities for SARS-CoV-2 and dengue virus: A South-South collaborative partnership.

Sully Márquez, Gerald Vasquez-Aleman, Jose G Juarez, Cristhiam Cerpas, Paul Cardenas, Shannon Bennett, Angel Balmaseda, Eva Harris, Josefina Coloma

Abstract read
In one paragraph

Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Sully MárquezUniversidad San Francisco de Quito, Quito, Ecuador.
Gerald Vasquez-AlemanSustainable Sciences Institute, Managua, Nicaragua.
Jose G JuarezSustainable Sciences Institute, Managua, Nicaragua.ORCID https://orcid.org/0000-0002-0583-478X
Cristhiam CerpasSustainable Sciences Institute, Managua, Nicaragua.ORCID https://orcid.org/0009-0008-9692-5935
Paul CardenasUniversidad San Francisco de Quito, Quito, Ecuador.
Shannon BennettCalifornia Academy of Sciences, California, United State of America.
Angel BalmasedaLaboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministerio de Salud, Managua, Nicaragua.
Eva HarrisDivision of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, California, United State of America.
Josefina ColomaDivision of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, California, United State of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Latin American countries have faced limited access to new scientific technologies for many years due to restricted budgets for research programs, which has hindered local scientific development. These research disparities became especially evident during the COVID-19 pandemic, as lower-middle-income countries (LMICs) like Ecuador and Nicaragua had restricted access to genomic surveillance protocols, sequencing technologies, and adequate infrastructure, compromising global pandemic preparedness and response. In response to the urgent need for SARS-CoV-2 research capabilities in these countries, the Asian-American Center for Arbovirus Research and Enhanced Surveillance led the initiative, collaborating with the NGO Sustainable Sciences Institute and LMIC stakeholders, including universities and Ministries of Health, to develop pandemic-related research programs, provide resources, and conduct peer training workshops for local health scientists. Over the past five years, collaborative efforts have enabled teams in Ecuador and Nicaragua to establish sustainable research capacity and technology-sharing initiatives, as showcased by the institutionalization of government-led genomic surveillance efforts. This has opened new research opportunities in genomic surveillance for other emerging and reemerging pathogens and strengthening South-South collaboration.

Identifiers

PMID40198614
PMCPMC11978052

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.